The association of telomere length and cancer: A meta-analysis

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 6, 2011, Pages 1238-1250

  Wentzensen, Ingrid M ^a   Mirabello, Lisa ^a   Pfeiffer, Ruth M ^a   Savage, Sharon A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CANCER; BREAST CANCER; CASE CONTROL STUDY; COLORECTAL CANCER; ESOPHAGUS CANCER; HEAD AND NECK CANCER; HUMAN; KIDNEY CANCER; LUNG CANCER; MEDLINE; MELANOMA; NEOPLASM; NONHODGKIN LYMPHOMA; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SKIN CANCER; STOMACH CANCER; TELOMERE; TELOMERE LENGTH;

CASE-CONTROL STUDIES; CHROMOSOMAL INSTABILITY; HUMANS; NEOPLASMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; TELOMERE;

EID: 79958072402     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-11-0005     Document Type: Article

References (63)

1. Palm W, de LT. How shelterin protects mammalian telomeres. Annu Rev Genet 2008;42:301-34.
2. Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008;88:557-79. (Pubitemid 351522746)
3. Hornsby PJ. Short telomeres: cause or consequence of aging? Aging Cell 2006;5:577-8.
4. Shawi M, Autexier C. Telomerase, senescence and ageing. Mech Ageing Dev 2008;129:3-10.
5. Baird DM. Mechanisms of telomeric instability. Cytogenet Genome Res 2008;122:308-14.
6. Campisi J, Kim SH, Lim CS, Rubio M. Cellular senescence, cancer and aging: the telomere connection. Exp Gerontol 2001;36:1619-37. (Pubitemid 32982869)
7. Hackett JA, Greider CW. Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis. Oncogene 2002;21:619-26.
8. Shay JW, Zou Y, Hiyama E, Wright WE. Telomerase and cancer. Hum Mol Genet 2001;10:677-85. (Pubitemid 32331575)
9. Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in dyskeratosis congenita. Blood 2009;113:6549-57.
10. Alter BP, Baerlocher GM, Savage SA, Chanock SJ, Weksler BB, Willner JP, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita. Blood 2007;110:1439-47. (Pubitemid 47443958)
11. Wu X, Amos CI, Zhu Y, Zhao H, Grossman BH, Shay JW, et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003;95:1211-8. (Pubitemid 37069551)
12. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005;26:1263-71. (Pubitemid 41417904)
13. De Vivo I, Prescott J, Wong JY, Kraft P, Hankinson SE, Hunter DJ, et al. A prospective study of relative telomere length and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:1152-6.
14. Gramatges MM, Telli ML, Balise R, Ford JM. Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls. Cancer Epidemiol Biomarkers Prev 2010;19:605-13.
15. Han J, Qureshi AA, Prescott J, Guo Q, Ye L, Hunter DJ, et al. A prospective study of telomere length and the risk of skin cancer. J Invest Dermatol 2009;129:415-21.
16. Hosgood HD III, Cawthon R, He X, Chanock S, Lan Q. Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. Lung Cancer 2009;66:157-61.
17. Hou L, Savage SA, Blaser MJ, Perez-Perez G, Hoxha M, Dioni L, et al. Telomere length in peripheral leukocyte DNA and gastric cancer risk. Cancer Epidemiol Biomarkers Prev 2009;18:3103-9.
18. Jang JS, Choi YY, Lee WK, Choi JE, Cha SI, Kim YJ, et al. Telomere length and the risk of lung cancer. Cancer Sci 2008;99:1385-9. (Pubitemid 351761728)
19. Lan Q, Cawthon R, Shen M, Weinstein SJ, Virtamo J, Lim U, et al. A prospective study of telomere length measured by monochrome multiplex quantitative PCR and risk of non-Hodgkin lymphoma. Clin Cancer Res 2009;15:7429-33.
20. Lee IM, Lin J, Castonguay AJ, Barton NS, Buring JE, Zee RY, et al. Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study. Clin Chem Lab Med 2010;48:259-62.
21. Liu X, Bao G, Huo T, Wang Z, He X, Dong G, et al. Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci 2009;100:1300-5.
22. McGrath M, Wong JY, Michaud D, Hunter DJ, De V I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007;16:815-9. (Pubitemid 46650587)
23. Mirabello L, Huang WY, Wong JY, Chatterjee N, Reding D, Crawford ED, et al. The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer. Aging Cell 2009;8:405-13.
24. Mirabello L, Garcia-Closas M, Cawthon R, Lissowska J, Brinton LA, Pepøońska B, et al. Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot study. Cancer Causes Control 2010;21:77-82.
25. Pooley KA, Sandhu MS, Tyrer J, Shah M, Driver KE, Luben RN, et al. Telomere length in prospective and retrospective cancer case-control studies. Cancer Res 2010;70:3170-6.
26. Prescott J, McGrath M, Lee IM, Buring JE, De V I. Telomere length and genetic analyses in population-based studies of endometrial cancer risk. Cancer 2010;116:4275-82.
27. Risques RA, Vaughan TL, Li X, Odze RD, Blount PL, Ayub K, et al. Leukocyte telomere length predicts cancer risk in Barrett's Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007;16:2649-55. (Pubitemid 351210548)
28. Shen J, Terry MB, Gurvich I, Liao Y, Senie RT, Santella RM, et al. Short telomere length and breast cancer risk: a study in sister sets. Cancer Res 2007;67:5538-44. (Pubitemid 46997296)
29. Shen J, Gammon MD, Terry MB, Wang Q, Bradshaw P, Teitelbaum SL, et al. Telomere length, oxidative damage, antioxidants and breast cancer risk. Int J Cancer 2009;124:1637-43.
30. Svenson U, Roos G. Telomere length as a biological marker in malignancy. Biochim Biophys Acta 2009;1792:317-23.
31. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstätter A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010;304:69-75.
32. Xing J, Ajani JA, Chen M, Izzo J, Lin J, Chen Z, et al. Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. Cancer Prev Res 2009;2:459-65.
33. Zee RY, Castonguay AJ, Barton NS, Buring JE. Mean telomere length and risk of incident colorectal carcinoma: a prospective, nested case-control approach. Cancer Epidemiol Biomarkers Prev 2009;18:2280-2.
34. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
35. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009;37:e21.
36. Shao L, Wood CG, Zhang D, Tannir NM, Matin S, Dinney CP, et al. Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer. J Urol 2007;178:1492-6. (Pubitemid 47368377)
37. Zheng YL, Ambrosone C, Byrne C, Davis W, Nesline M, McCann SE. Telomere length in blood cells and breast cancer risk: investigations in two case-control studies. Breast Cancer Res Treat 2010;120:769-75.
38. Zheng YL, Loffredo CA, Shields PG, Selim SM. Chromosome 9 arm-specific telomere length and breast cancer risk. Carcinogenesis 2009;30:1380-6.
39. Baerlocher GM, Vulto I, de JG, Lansdorp PM. Flow cytometry and FISH to measure the average length of telomeres (flow FISH). Nat Protoc 2006;1:2365-76.
40. Widmann TA, Herrmann M, Taha N, Konig J, Pfreundschuh M. Short telomeres in aggressive non-Hodgkin's lymphoma as a risk factor in lymphomagenesis. Exp Hematol 2007;35:939-46. (Pubitemid 46802988)
41. Baird DM. New developments in telomere length analysis. Exp Gerontol 2005;40:363-8. (Pubitemid 40775728)
42. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
43. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
44. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
45. Higgins JP. Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008;37:1158-60.
46. Svenson U, Nordfjäll K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008;68:3618-23.
47. Fordyce CA, Heaphy CM, Joste NE, Smith AY, Hunt WC, Griffith JK, et al. Association between cancer-free survival and telomere DNA content in prostate tumors. J Urol 2005;173:610-4.
48. Gadalla SM, Cawthon R, Giri N, Alter BP, Savage SA. Telomere length in blood, buccal cells, and fibroblasts from patients with inherited bone marrow failure syndromes. Aging 2010;2:867-74.
49. Heaphy CM, Bisoffi M, Fordyce CA, Haaland CM, Hines WC, Joste NE, et al. Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors. Int J Cancer 2006;119:108-16.
50. Engelhard M, Sack H. [Radiotherapy alone in early stages of low malignancy non-Hodgkin lymphomas]. Praxis 1998;87:801-5.
51. Schroder CP, Wisman GB, de JS, van der Graaf WT, Ruiters MH, Mulder NH, et al. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 2001;84:1348-53. (Pubitemid 32522103)
52. Lee JJ, Nam CE, Cho SH, Park KS, Chung IJ, Kim HJ, et al. Telomere length shortening in non-Hodgkin's lymphoma patients undergoing chemotherapy. Ann Hematol 2003;82:492-5.
53. Epel ES. Psychological and metabolic stress: a recipe for accelerated cellular aging? Hormones 2009;8:7-22.
54. Kim S, Parks CG, DeRoo LA, Chen H, Taylor JA, Cawthon RM, et al. Obesity and weight gain in adulthood and telomere length. Cancer Epidemiol Biomarkers Prev 2009;18:816-20.
55. Radpour R, Barekati Z, Haghighi MM, Kohler C, Asadollahi R, Torbati PM, et al. Correlation of telomere length shortening with promoter methylation profile of p16/Rb and p53/p21 pathways in breast cancer. Mod Pathol 2010;23:763-72.
56. Kyo S, Takakura M, Kanaya T, Zhuo W, Fujimoto K, Nishio Y, et al. Estrogen activates telomerase. Cancer Res 1999;59:5917-21. (Pubitemid 30004951)
57. Stindl R. Tying it all together: telomeres, sexual size dimorphism and the gender gap in life expectancy. Med Hypotheses 2004;62:151-4. (Pubitemid 38200023)
58. von ZT, Saretzki G, Docke W, Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence? Exp Cell Res 1995;220:186-93.
59. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-4. (Pubitemid 41176019)
60. Rufer N, Brümmendorf TH, Kolvraa S, Bischoff C, Christensen K, Wadsworth L, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med 1999;190:157-67. (Pubitemid 29354909)
61. Friedrich U, Griese E, Schwab M, Fritz P, Thon K, Klotz U, et al. Telomere length in different tissues of elderly patients. Mech Ageing Dev 2000;119:89-99.
62. Mondello C, Petropoulou C, Monti D, Gonos ES, Franceschi C, Nuzzo F, et al. Telomere length in fibroblasts and blood cells from healthy centenarians. Exp Cell Res 1999;248:234-42. (Pubitemid 29393946)
63. Fern L, Pallis M, Ian CG, Seedhouse C, Russell N, Byrne J, et al. Clonal haemopoiesis may occur after conventional chemotherapy and is associated with accelerated telomere shortening and defects in the NQO1 pathway; possible mechanisms leading to an increased risk of t-AML/MDS. Br J Haematol 2004;126:63-71. (Pubitemid 38859483)